AI assistant
Sending…
Cigna Group — Director's Dealing 2021
Jan 8, 2021
29918_dirs_2021-01-08_076452fd-7284-429f-870e-d3ca1c2c471d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2021-01-01
Reporting Person: Neville Everett (EVP, Strategy and Business Dev)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 Par Value | 7371.0000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $176.6556 | 2025-03-04 | Common Stock, $.01 Par Value (192.0000) | Direct | |
| Employee Stock Option (Right to Buy) | $192.0200 | 2030-02-26 | Common Stock, $.01 Par Value (8340.0000) | Direct | |
| Phantom Stock Units | $0.0000 | Common Stock, $.01 Par Value (418.6865) | Direct |
Footnotes
F1: This option is fully vested.
F2: This option vests in three equal annual installments beginning February 26, 2021.
F3: Phantom Stock Units credited under Express Scripts Executive Deferred Compensation Plan.
F4: These Phantom Stock Units are fully vested.
F5: Upon distribution, each Phantom Stock Unit converts to one share of Cigna Corporation Common Stock.
More from Cigna Group
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4